Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Above averageGE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “our,” “us,” or “we”) is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. We have approximately 54,000 colleagues dedicated to our purpose to create a world where healthcare has no limits. Serving patients and providers for nearly 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalized, precise patient care.
In the company’s own words · 10-K filed Feb 4, 2026 · SEC EDGAR
Business segments
Jun 2026 · $3.73BThe company’s own SEC segment disclosure.
- AIS$2.39B64%
- P Dx$843.0M23%
- PCS$503.0M13%
GE HealthCare (GEHC) reported revenue of $5.13B in Q1 2026 (quarter ended Mar 31, 2026), up 7.4% from the same quarter a year earlier. That came with a gross margin of 39% and net income of $389M (7.6% of revenue). For the full year FY2025, revenue was $20.6B (+4.8% year on year) and net income $2.08B. Its largest segment in Jun 2026 was AIS at $2.39B, 64% of the disclosed total, well ahead of P Dx at 23%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Devices
The closest names by size in the same industry